Newsletter

000100 - Yuhan Corporation

000100 Summary
Biopharma
Stock Price & Overview
₩81,400 +0 (+0.00%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩81,400  ≈ US$58  ·  Market cap ₩6.0tn (≈ $4.3bn)
Home › 000100 › Filings

Quarterly Report

DART
Yuhan Corporation
Filed May 15, 2026 KST · Periodic · receipt 20260515002331

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 분기보고서 (2026.03)

000100

Price
₩81,400
Change
+0.00%
Market cap
₩6.0tn
Prev. close
₩81,400
000100 SummaryCompare to Peers

More 000100 filings

Yuhan signs $95m API supply deal with an undisclosed global drugmaker

09/01/26

Serious industrial accident (subsidiary)

08/25/26

Fair-trade compliance programme status (notice)

08/24/26

Investor Relations Event

08/18/26

Half-Year Report

08/14/26

5% Ownership Report — Short Form

08/10/26